PAUL B. OSSI, M.D.

JACKSONVILLE, FL

Research Active
Radiology - Radiation Oncology NPI registered 21+ years 2 publications 1998 – 2002 NPI: 1972508299
Radiology - Radiation Oncology
Uterine Cervical NeoplasmsNeoplasm StagingBrain NeoplasmsBrachytherapyRadiotherapy DosageLymphoma, B-CellSurvival AnalysisRadiotherapy, High-EnergyCranial IrradiationEye Neoplasms

Practice Location

10881 SAN JOSE BLVD
JACKSONVILLE, FL 32223-6612

Phone: (904) 387-9525

What does PAUL OSSI research?

Dr. Ossi studies the effectiveness of different treatment methods for patients with cervical cancer and ocular adnexal lymphoma. In cervical cancer, he investigates how varying the number of radiation implants influences patient outcomes. His research indicates that while receiving two implants may deliver more radiation, it does not significantly improve survival rates or reduce disease recurrence over five years. In ocular adnexal lymphoma, he looks at the necessity of preventative treatments aimed at the central nervous system, finding that such precautions are largely unnecessary as the risk of cancer spreading there is very low. Overall, his work is centered on optimizing cancer care and avoiding unnecessary interventions.

Key findings

  • In the cervical cancer study involving 86 patients, there was no significant difference in survival or disease-free rates between those receiving one or two brachytherapy implants after five years.
  • Only 15% of the 71 patients studied with ocular adnexal lymphoma had a history of other cancers, and none experienced cancer spread to the eye or central nervous system during the study period.
  • Dr. Ossi's findings suggest that the routine use of CNS preventative treatments in ocular adnexal lymphoma patients is unnecessary.

Frequently asked questions

Does Dr. Ossi study cervical cancer?
Yes, he researches treatment methods for cervical cancer, especially focusing on brachytherapy techniques.
What treatments has Dr. Ossi researched?
He has researched the use of radiation therapy in cervical cancer and the necessity of CNS prophylaxis in ocular adnexal lymphoma.
Is Dr. Ossi's work relevant to lymphoma patients?
Yes, his studies help lymphoma patients by clarifying treatment protocols, particularly regarding the need for preventative CNS treatments.
What is brachytherapy?
Brachytherapy is a form of cancer treatment where radioactive materials are placed inside or near a tumor to deliver a high dose of radiation directly to the cancer.
How can this research impact patient care?
His findings can help healthcare providers make informed decisions about the most effective treatments and avoid unnecessary procedures.

Publications in plain English

University of Miami experience using one versus two intracavitary brachytherapy implants.

2002

American journal of clinical oncology

Abdel-Wahab M, Wolfson A, Ossi P, Raub W, Markoe A

Plain English
This study looked at how the number of brachytherapy implants—either one or two—affected the outcomes for 86 patients with cervical cancer treated with radiation. The researchers found that while those who received two implants got a higher total radiation dose, there was no significant difference in overall survival or the chance of being disease-free between the two groups after five years. This research is important because understanding the best treatment approach can help improve care for cervical cancer patients. Who this helps: This helps patients with cervical cancer and their healthcare providers.

PubMed

Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?

1998

Critical reviews in oncogenesis

Restrepo A, Raez LE, Byrne GE, Johnson T, Ossi P +4 more

Plain English
This study looked at 71 patients with a type of cancer called ocular adnexal lymphoma, focusing on whether this cancer spreads to the eye or central nervous system (CNS). Researchers found that only 15% of patients had previous cancers, but none had cancer that spread to the eye or CNS during the study period. This means that giving patients preventative treatments for the CNS is not needed, as spreading to that area is very uncommon. Who this helps: This helps doctors and patients by indicating that they can avoid unnecessary CNS treatments.

PubMed

Frequent Co-Authors

May Abdel-Wahab Aaron Wolfson William Raub Arnold Markoe A Restrepo L E Raez G E Byrne T Johnson P Benedetto K Hamilton

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.